Pharmabiz1h
Astellas Pharma seeks Japanese conditional approval of avacincaptad pegol intravitreal solution to treat geographic atrophy
Astellas Pharma seeks Japanese conditional approval of avacincaptad pegol intravitreal solution to treat geographic atrophy: Tokyo Thursday, February 6, 2025, 09:00 Hrs [IST] Aste ...
Pharmabiz2h
New norms for nasal spray of ASU drugs to bring in uniformity in composition & efficacy: Experts
Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
Centre estimates to transfer Rs. 50 crore for strengthening state drug regulatory system in FY26
The Budget Estimates (BE) for the Centrally Sponsored Scheme of Strengthening of States Drug Regulatory System (SSDRS) for the fiscal year 2025-26 is Rs. 50 crore, around 33 per cent less than the ...
Pharmabiz2h
Panel asks Centre to consider covering cost of medicines for long term treatment under PMJAY
Panel asks Centre to consider covering cost of medicines for long term treatment under PMJAY: Gireesh Babu, New Delhi Thursday, February 6, 2025, 08:00 Hrs [IST] A Parliamentary P ...
Pharmabiz2h
TNCDA launches drive to bring back members who left the association due to factional feuds
Peethaambaran Kunnathoor, Chennai Thursday, February 6, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
Dr Sanjay Agrawal applies for patent for anti-aging medicine
Dr Sanjay Agrawal, a renowned pharmaceutical consultant and scientific advisor of Alkomex GBN Pharma Group USA, has recently applied for a patent for an anti-aging formulation. Dr Agrawal has ...
Pharmabiz18h
Jaguar Health begins patient dosing in short bowel syndrome with intestinal failure in investigator-initiated trial of crofelemer
San Francisco, California Wednesday, February 5, 2025, 16:00 Hrs [IST] ...
Pharmabiz16h
Algiax Pharma announces positive data from phase 2a trial evaluating AP-325 in patients with neuropathic pain
Düsseldorf, Germany Wednesday, February 5, 2025, 18:00 Hrs [IST] ...
Pharmabiz19h
Model N highlights 99% life sciences and high-tech leaders expect AI to drive finance management
Our Bureau, Bengaluru Wednesday, February 5, 2025, 14:30 Hrs [IST] ...
Pharmabiz20h
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...
Pharmabiz21h
Sirius Medical secures scale-up funding to further advance its surgical marker navigation portfolio and expand its global presence
Sirius Medical secures scale-up funding to further advance its surgical marker navigation portfolio and expand its global presence: Eindhoven, the Netherlands Wednesday, February ...
Pharmabiz21h
JB Pharma reports revenue growth of 14% to Rs. 963 crore in Q3 FY25 net profit increased by 22% to Rs. 162 crore
JB Pharma reports revenue growth of 14% to Rs. 963 crore in Q3 FY25 net profit increased by 22% to Rs. 162 crore: Our Bureau, Mumbai Wednesday, February 5, 2025, 12:20 Hrs [IST] J ...